Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy
Evelina Miele,1,* Gian Paolo Spinelli,2,* Ermanno Miele,3 Enzo Di Fabrizio,3,6 Elisabetta Ferretti,4 Silverio Tomao,2 Alberto Gulino,1,5 1Department of Molecular Medicine, 2Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, 3Nanostructures, Istituto Italia...
Guardado en:
Autores principales: | Miele E, Spinelli GP, Di Fabrizio E, Ferretti E, Tomao S, Gulino A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/31e3771766b4460180d05bf7b6ea2bf1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
por: Evelina Miele, et al.
Publicado: (2009) -
Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach
por: Mahmoodi Chalbatani G, et al.
Publicado: (2019) -
Effective small interfering RNA delivery in vitro via a new stearylated cationic peptide
por: Chen BL, et al.
Publicado: (2015) -
Gene interfered-ferroptosis therapy for cancers
por: Jinliang Gao, et al.
Publicado: (2021) -
Enhanced endosomal escape by photothermal activation for improved small interfering RNA delivery and antitumor effect
por: Yang X, et al.
Publicado: (2018)